期刊文献+

降血尿酸乳酸菌筛选及其对高尿酸血症模型大鼠作用研究 被引量:10

Screening of serum uric acid-lowering Lactic acid bacteria and its effect on hyperuricemia in rat models
原文传递
导出
摘要 目的提出利用具特殊活性乳酸菌来预防、治疗高尿酸血症方法,筛选具有较高降血尿酸活性的乳酸菌。方法基于RP-HPLC方法,通过检测培养液培养前后肌苷、鸟苷含量变化,筛选出具有最快核苷分解速率的乳酸菌株作为候选菌株。并将其施用于高尿酸血症模型大鼠,观察对模型大鼠血尿酸含量影响。结果获得具有最佳核苷分解速率的菌株DM9218。动物实验结果表明DM9218干预组的血尿酸浓度(219.25±21.98)μmol/L明显低于模型组(311.75±27.07)μmol/L(P<0.05)。结论菌株DM9218具有最快的核苷分解速率,对高尿酸血症大鼠具有明显的降血尿酸作用。菌株DM9218为植物乳杆菌(Lactobacillus plantarum)。 Objective To propose a method for the prevention and treatment of hyperuricemia by Lactic acid bacteria(LAB) with specific activity,and screen LAB strains with high serum uric acid-lowering activity.Methods Based on RP-HPLC method,the changes of inosine and guanosine contents in the culture medium before and after cultivation were determined;The LAB strains which presented the fastest rates of decomposition of nucleosides were selected as the candidate strains,and administered to the model rats.The effect of the strains on the serum uric acid level of the rats were observed.Results The strain DM9218 with an optimal decomposition rate of nucleoside was obtained.Animal experimental results showed that the serum uric acid level of DM9218 intervention group [(219.25 ± 21.98) μmol/L] was obviously lower than that of the model group [(311.75 ± 27.07) μmol/L](P〈0.05).Conclusion DM9218 has the fastest decomposition rate of nucleosides and obvious effect of lowering serum uric acid in hyperuricemia rats.DM9218 is identified as Lactobacillus plantarum.
出处 《中国微生态学杂志》 CAS CSCD 2013年第2期125-128,共4页 Chinese Journal of Microecology
基金 "十二五"科技支撑项目(2012BAI35B02)
关键词 高尿酸血症 降血尿酸 乳酸菌 Hyperuricemia Reducing blood uric acid Lactic acid bacteria
  • 相关文献

参考文献8

二级参考文献69

共引文献77

同被引文献82

  • 1洪岩,张越.非布司他、苯溴马隆、别嘌呤醇治疗高尿酸血症的安全性和有效性比较[J].四川解剖学杂志,2020,0(1):96-98. 被引量:14
  • 2郁颖佳,郑晓伟,黄滔敏,段更利.高效液相色谱法测定人体血浆中尿酸的浓度[J].复旦学报(医学版),2006,33(2):273-275. 被引量:9
  • 3孙进,乐国伟,施用晖,苏广伟.乳酸菌的黏液黏附特性及其影响因素[J].中华微生物学和免疫学杂志,2006,26(6):525-525. 被引量:2
  • 4久米村慧,池永武,冈松洋,等.降低血清尿酸水平的组合物发明专利申请公开说明书[P].200480017815.5:1.
  • 5Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension [ J ]. Vasc Health Risk Manag, 2014 , (10) :253-261.
  • 6Kontogianni MD, Chrysohoou C, Panagiotakos DB, et al. Adher- ence to the Mediterranean diet and serum uric acid: the ATYICA study [ J ]. Scand J Rheumatol, 2012,41 (6) :442449.
  • 7Hediger MA, Johnson R J, Miyazaki H, et al. Mo|ecular Physiolo- gy of Urate Transport[J]. Physiology,2005, 20(2) :125-133.
  • 8Hosomi A, Nakanishi T, Fujita T, et al. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2 [ J ]. PLoS One, 2012,7(2) :e30456.
  • 9Vitetta L, Gobe G. Uremia and chronic kidney disease : the role Of the gut microflora and therapies with pro- and prebiotics [ J 1. Mol Nutr Food Res ,2013, 57 ( 5 ) : 824-832.
  • 10Bai YH, Jiang YF, Jiang YS. Lactobacillus bulgaricus mutants decompose uremic toxins[ J ]. Ren Fail, 20!4 ,36 (5) :790-794.

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部